Global Precision Medicine Market (2018-2023)

Precision Medicine Market has benefitted greatly from advancements in the life science industry. Although in its nascent stage, targeted therapies hold high chances of becoming a massive success in the coming years because of the potential to treat and cure chronic illnesses. The market is thus expected to expand at a compound annual growth rate (CAGR) of 11.60% between 2018 and 2023, generating USD 88.25 Bn in revenue by 2023.

Request for Sample with TOC@ https://www.researchtrades.com/request-sample/1734160

Ecosystem player segment insights
Diagnostic companies held the largest share of the market in 2018, contributing to approximately 39% of the global revenues. They are expected to continue dominating the market during the assessment period, owing to the dominant role that precision medicine plays in diagnosing potential diseases. Pharmaceutical companies are next in line to dominate the market, accounting for a market share of 29% in 2018 due to the increasing efforts put in research and development for developing drugs.

Therapeutic segment insights
Among the therapeutic areas of precision medicine, cancer held the largest share of the market by generating almost 33% of the global market revenue in 2018. Development of targeted novel therapies and precision medicines for treating cancer, owing to its increasing prevalence worldwide, will drive its growth in the foreseeable future. Central nervous system (CNS) disorders and infectious diseases held market shares of 20% and 16%, respectively. The precision medicine market for respiratory diseases is foreseen to grow at a very high rate, owing to the growth of diseases such as asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, etc.

Technology segment insights
Pharmacogenomics held the largest market share (24%) in 2018, followed by genomics. The technological and analytical developments in genomics have made it easier to identify and interpret the genetic variation underlying a disease, thereby contributing to the rapid growth of genomics. The market for genomics is also projected to expand at the highest CAGR of 13.67% during 2018?2023. Big data analytics is also expected to show fast growth during the forecast period.

Regional insights
North America leads the global precision medicine market with a share of 43%, followed by Europe with a 26% share. These regions are primarily driven by supportive policies and initiatives by the government, a strong presence of market players, and quick adoption of advanced healthcare technology and practices. Asia-Pacific is expected to emerge as the fastest growing region in this market with the highest CAGR of 13% during the forecast period.

Companies covered
- Abbott Laboratories
- GE Healthcare
- GlaxoSmithKline (GSK)
- Johnson & Johnson
- Pfizer
- Randox Laboratories
- Almac Group
- Novartis AG
- Teva Pharmaceutical industries
- Quest Diagnostics

Request for discount@ https://www.researchtrades.com/discount/1734160

Contact us:
Email: sales@researchtrades.com
Call us: +1 6269994607 / +91 7507349866
Skype ID: researchtradescon
Web: www.researchtrades.com

Who we are
Research Trades has a team of experts who is working on a comprehensive analysis of market research. This estimate is based on a comprehensive study of the future and estimates of future estimates, which can be used by various organizations for growth purposes.
We distribute customized reports that focus on meeting the customer’s specific requirement.
Our company provides a large collection of high-quality reports obtained by customer-centered approaches, thus providing valuable research insights.

This release was published on openPR.